Out of hospital management of LVAD patients during COVID-19 outbreak.
Silvia MarianiJasmin S HankeGünes DoganJan D SchmittoPublished in: Artificial organs (2020)
Coronavirus disease 2019 (COVID-19) is a pandemic touching thousands of people all around the world. Patients supported with left ventricular assist devices (LVADs) are affected by long-standing cardiovascular diseases and subjected to variations of the normal cardiovascular physiology, thus requiring an even closer monitoring during the COVID-19 outbreak. Nevertheless, the COVID-19 pandemic led to a drastic reduction in routine clinical activities and a consequent risk of looser connections between LVAD patients and their referring center. Potential deleterious effects of such a situation can be a delayed recognition of LVAD-related complications, misdiagnosis of COVID-19, and impaired social and psychological well-being for patients and families. As one of the largest LVAD programs worldwide, we designed a sustainable and enforceable telemonitoring algorithm which can be easily adapted to every LVAD center so as to maintain optimal quality of care for LVAD patients during the COVID-19 pandemic.
Keyphrases
- coronavirus disease
- end stage renal disease
- ejection fraction
- chronic kidney disease
- newly diagnosed
- cardiovascular disease
- peritoneal dialysis
- type diabetes
- heart failure
- public health
- machine learning
- emergency department
- risk factors
- risk assessment
- atrial fibrillation
- acute myocardial infarction
- physical activity
- patient reported
- left ventricular assist device
- electronic health record
- sleep quality
- left atrial